Skip to content

Public FDA record

Z-1106-05: Staarvisic II Sodium Hyaluronate, 0.8 mL

Recall record Z-1106-05 for Staar Surgical Co Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1106-05
Company in FDA record
Staar Surgical Co Inc
FDA classification date
Aug 6, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Sterility may be compromised.

Source facts

Action
Recall will be communicated by telephone, email and letter. A fax back form will be used to track response and to identify ammount on hand.
Initiated
2005-07-18
Root cause
Other
Terminated
2012-07-25
Distribution
Nationwide, Canada and Puerto Rico
Recall number
Z-1106-05
Recall status
Terminated
CDRH record ID
40838
FDA classified
2005-08-06
Recall event number
32798

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗